Clara Vincentelli

ORCID: 0000-0002-3164-8307
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pituitary Gland Disorders and Treatments
  • Bone and Joint Diseases
  • Ovarian function and disorders
  • Body Contouring and Surgery
  • Venous Thromboembolism Diagnosis and Management
  • Adrenal and Paraganglionic Tumors
  • Diabetes and associated disorders
  • Diabetes Treatment and Management
  • Dermatological and Skeletal Disorders
  • Cardiovascular Health and Disease Prevention
  • Bariatric Surgery and Outcomes
  • Cardiovascular Function and Risk Factors
  • Growth Hormone and Insulin-like Growth Factors
  • Cardiovascular Disease and Adiposity
  • Hematological disorders and diagnostics
  • Gestational Diabetes Research and Management
  • Assisted Reproductive Technology and Twin Pregnancy
  • COVID-19 Clinical Research Studies
  • Hip disorders and treatments
  • Retinal Diseases and Treatments
  • Diagnosis and Treatment of Venous Diseases
  • Pancreatitis Pathology and Treatment
  • Adrenal Hormones and Disorders
  • Pancreatic function and diabetes

Aix-Marseille Université
2018-2019

Inserm
2017-2019

Assistance Publique Hôpitaux de Marseille
2018-2019

Unité de recherche sur les maladies cardiovasculaires et métaboliques
2018

Hôpital de la Conception
2017-2018

Nutrition, Obésité et Risque Thrombotique
2017

Abstract Aims Recent trials provide conflicting results on the association between glucagon-like peptide 1 receptor agonists (GLP-1RA) and diabetic retinopathy (DR). The aim of AngioSafe type 2 diabetes (T2D) study was to determine role GLP-1RA in angiogenesis using clinical preclinical models. Methods We performed two studies humans. In 1, we investigated effect exposure from T2D diagnosis severity DR, as diagnosed with retinal imaging (fundus photography). 2, a randomized 4-week trial,...

10.1210/clinem/dgz069 article EN The Journal of Clinical Endocrinology & Metabolism 2019-10-07

Glucocorticoid excess is one of the most important causes bone disorders. Bone marrow fat (BMF) has been identified as a l new mediator metabolism. Cushing syndrome (CS), main regulator adipose tissue distribution but its impact on BMF unknown. The objective study was to evaluate effect chronic hypercortisolism BMF.This cross-sectional study. Seventeen active and seventeen cured ACTH-dependent CS patients along with controls (matched group for age sex) were included.the content femoral neck...

10.1530/eje-18-0318 article EN European Journal of Endocrinology 2018-08-14

Avec l’âge maternel et le tabac, l’IMC est un facteur pronostic important de la fertilité d’une femme. Chez une femme obèse, prise en charge hygiéno-diététique préconceptionnelle doit être mise place précocement amont du désir grossesse, à fois pour améliorer fertilité, mais aussi diminuer les futures complications obstétricales. En cas d’infertilité, patiente obèse devra tenir compte son âge l’association ou non syndrome des ovaires polykystiques (SOPK). Une perte poids recommandée chez...

10.1007/s11690-017-0559-8 article FR Obésité 2017-09-01
Coming Soon ...